Phase I study of ascending doses of the cytotoxic immunoconjugate CMB-401 in patients with epithelial ovarian cancer
1998
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI